Brief: Iterum Therapeutics To Renew Efforts For Strategic Transaction Involving ORLYNVAH
25/10/2024 19:08
Oct 25 (Reuters) - Iterum Therapeutics PLC ITRM.O :
* ITERUM THERAPEUTICS PLC - TO RENEW EFFORTS FOR STRATEGIC
TRANSACTION INVOLVING ORLYNVAH
* ITERUM: IN CASE STRATEGIC PROCESS DOES NOT RESULT IN A
DEAL, MAY
SEEK COMMERCIAL PARTNER AND/OR LOOK TO COMMERCIALIZE ORAL
SULOPENEM IN US DIRECTLY
Source text for Eikon: ID:n0000950170-24-117270
Further company coverage: ITRM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Iterum Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Entergy, US natgas stocks, Brown-Forman, Datacentrex
U.S. STOCKS ON THE MOVE-Entergy, IDEX Corp, Quanta Services
Iterum Therapeutics plummets after filing wind up petition
Iterum seeks court-led dissolution amid cash crisis, inability to raise funds (updated)
Iterum files wind-up petition due to limited cash, inability to raise equity